Evidence map›Paper›PMID 35526186›Full record

ArticleAdvances in biochemical engineering/biotechnology2022

Overview on Glycosylated Lipids Produced by Bacteria and Fungi: Rhamno-, Sophoro-, Mannosylerythritol and Cellobiose Lipids.

Susanne Zibek, Gloria Soberón-Chávez

Abstract read
PubMed Publisher
In one paragraph

Article in Advances in biochemical engineering/biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Susanne ZibekBioprocess Engineering Division, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart, Germany.
Gloria Soberón-ChávezDepartamento de Biología Molecular y Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City, Mexico. gloria@iibiomedicas.unam.mx.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wide ranges of microorganisms produce glycosylated lipids (GL), which are characterized by their tensio-active properties. Therefore, they can be used in different industrial applications as biosurfactants, such as food, agriculture, cosmetics, and health products among others. Two GL biosurfactants, rhamnolipids (RL) and sophorolipids (SL), are now commercially available and share a significant part of the biosurfactant market that in 2017 represented about 2.5% of the total surfactants market, estimated at 15 million tons globally.In this chapter, we present a general overview of GL biosurfactants in terms of their diversity and the microorganisms that produce them. Additionally, we focus on the more detailed description of RL, SL, mannosylerythritol lipids (MEL), and cellobiose lipids (CL).Pseudomonas aeruginosa, the ubiquitous opportunistic pathogenic bacterium, is the best RL producer, but other non-pathogenic bacteria like Burkholderia thailandensis and Pseudomonas chlororaphis NRRL B-30761 are also capable of producing them naturally. In addition, Pseudomonas putida has been used as heterologous host to produce RL with good yields. Here we describe the biosynthetic pathway for RL production, the genes involved in its synthesis, and some of the challenges for producing a homogeneous RL product in high quantities that is suitable for specific applications.SL, MEL, and CL are some of the GL biosurfactants produced in high quantities by fungi, like Starmerella bombicola, Moesziomyces aphidis, or Ustilago maydis. We provide an overview of some of their characteristics, insights on the metabolic pathways involved in their synthesis and genetic modifications performed to increase their production, as well as fermentation and purification strategies and some of their applications.

Indexed as

CellobiosePseudomonas putidaFungiSurface-Active AgentsCellobioseSurface-Active AgentsCellobiose lipidsMannosylerythritol lipidsPseudomonasRhamnolipidsSophorolipidsStarmerella bombicolaUstilaginaceae

Identifiers

PMID35526186

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.